The Effects of Intravenous Heme Arginate on Heme Oxygenase-1 Expression (HO-1) and Oxidative Stress in the Human Heart
Clinical trial NCT02314780 · COMPLETED
Trial details
- NCT number
- NCT02314780
- Sponsor
- Martin Andreas, M.D.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-29
- Primary completion
- 2017-06-13
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.